Skip to Main Content

Advertisement

Skip Nav Destination

OnlineFirst

September 27 2023
Peritumoral immune suppressive mechanisms impede intratumoral lymphocyte infiltration into CRC liver versus lung metastases
Cancer Research Communications (2023)
September 27 2023
DNA2 nuclease inhibition confers synthetic lethality in cancers with mutant p53 and synergizes with PARP inhibitors
Cancer Research Communications (2023)
September 21 2023
Chromatin accessibility landscape of human triple-negative breast cancer cell lines reveals variation by patient donor ancestry
Cancer Research Communications (2023)
September 21 2023
Piperacetazine directly binds to the PAX3::FOXO1 fusion protein and inhibits its transcriptional activity.
Cancer Research Communications (2023)
September 20 2023
Metastatic competency and tumor spheroid formation are independent cell states governed by RB in lung adenocarcinoma
Cancer Research Communications (2023)
September 20 2023
The inherited KRAS-variant as a biomarker of Cetuximab Response in NSCLC
Cancer Research Communications (2023)
September 18 2023
Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project
Cancer Research Communications (2023)
September 13 2023
Combined targeting of NAD biosynthesis and the NAD-dependent transcription factor C-terminal Binding Protein as a promising novel therapy for pancreatic cancer
Cancer Research Communications (2023)
September 13 2023
Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer.
Cancer Research Communications (2023)
September 12 2023
Change in Neighborhood Socioeconomic Status and Adherence to the Cancer Prevention Lifestyle Guidelines in Hispanic/Latino Adults: Results from the HCHS/SOL Study
Cancer Research Communications (2023)
Close Modal

or Create an Account

Close Modal
Close Modal